We are live on ! Find out more
GNMK

GenMark Diagnostics, Inc
GNMK

Delisted

GNMK was delisted on the 21st of April, 2021.

Back to rankings

110 hedge funds and large institutions have $214M invested in GenMark Diagnostics, Inc in 2020 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 30 increasing their positions, 36 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

4% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 24

1% less funds holding

Funds holding: 111 → 110 (-1)

17% less repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 36

19% less capital invested

Capital invested by funds: $266M → $214M (-$51.3M)

26% less call options, than puts

Call options by funds: $682K | Put options by funds: $917K

Holders
110
Holders Change
-1
Holders Change %
-0.9%
% of All Funds
2.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
25
Increased
30
Reduced
36
Closed
24
Calls
$682K
Puts
$917K
Net Calls
-$235K
Net Calls Change
-$235K

Top Buyers

Rank Fund Capital Flow
1
PCM
Portolan Capital Management
Massachusetts
+$4.19M
2
Millennium Management
Millennium Management
New York
+$3.55M
3
Bank of America
Bank of America
North Carolina
+$3.25M
4
NIM
Needham Investment Management
New York
+$3.04M
5
EP
Eversept Partners
New York
+$2.46M

Top Sellers

Rank Fund Capital Flow
1
CCM
Cadian Capital Management
New York
-$9.51M
2
PCM
Penn Capital Management
Pennsylvania
-$4.7M
3
JP Morgan Chase
JP Morgan Chase
New York
-$4.08M
4
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$2.89M
5
Morgan Stanley
Morgan Stanley
New York
-$2.63M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$994K -$1.05K -224 -0.1%
EIM
27
Essex Investment Management
Massachusetts
$919K -$365K -77,825 -26%
Two Sigma Advisers
28
Two Sigma Advisers
New York
$887K -$228K -48,600 -18%
PHP
29
Parkman Healthcare Partners
Connecticut
$824K -$1.03M -220,000 -52%
LSC
30
Lyon Street Capital
California
$790K +$899K +191,656 New
D.E. Shaw & Co
31
D.E. Shaw & Co
New York
$670K -$2.22M -474,397 -74%
Russell Investments Group
32
Russell Investments Group
United Kingdom
$618K +$336K +71,732 +91%
Squarepoint
33
Squarepoint
New York
$607K -$418K -89,155 -38%
Deutsche Bank
34
Deutsche Bank
Germany
$522K -$701K -149,478 -54%
PCMI
35
Paradigm Capital Management Inc
New York
$489K +$87.2K +18,600 +19%
Wells Fargo
36
Wells Fargo
California
$478K -$498K -106,311 -48%
California Public Employees Retirement System
37
California Public Employees Retirement System
California
$460K – – –
TD Asset Management
38
TD Asset Management
Ontario, Canada
$437K – – –
Swiss National Bank
39
Swiss National Bank
Switzerland
$418K +$21.6K +4,600 +5%
Envestnet Asset Management
40
Envestnet Asset Management
Illinois
$400K +$147K +31,442 +48%
PM
41
Precept Management
Texas
$387K +$441K +94,000 New
RhumbLine Advisers
42
RhumbLine Advisers
Massachusetts
$386K -$2.34K -500 -0.5%
EPM
43
Equitec Proprietary Markets
Illinois
$366K +$71.7K +15,300 New
AllianceBernstein
44
AllianceBernstein
Tennessee
$347K +$88.6K +18,900 +29%
California State Teachers Retirement System (CalSTRS)
45
California State Teachers Retirement System (CalSTRS)
California
$345K -$13.3K -2,833 -3%
WI
46
WrapManager Inc
California
$330K +$56K +11,948 +18%
BAM
47
Bullseye Asset Management
Colorado
$325K -$1.46K -311 -0.4%
DCM
48
Donaldson Capital Management
Indiana
$301K +$46.9K +10,000 +16%
PAM
49
Panagora Asset Management
Massachusetts
$300K -$524K -111,841 -61%
Los Angeles Capital Management
50
Los Angeles Capital Management
California
$297K -$12.8K -2,720 -4%
1
2
3 4 5

GNMK Hedge Fund Activity: Q1 2020 in Review

110 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in GenMark Diagnostics, Inc (GNMK) for Q1 2020, worth a combined $214M — down 19% from $266M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new GNMK positions and 24 closed out — a net gain of 1 holder — while 30 added to existing stakes and 36 trimmed.

The largest buyer was Portolan Capital Management, opening a new position worth an estimated $4.19M. The largest seller was Cadian Capital Management, cutting an estimated $9.51M.

  • 110 institutional investors held GenMark Diagnostics, Inc (GNMK) as of Q1 2020, down from 111 in Q4 2019.
  • Funds reported $214M of GenMark Diagnostics, Inc stock for Q1 2020, down 19% quarter-over-quarter.
  • 25 funds opened new GenMark Diagnostics, Inc positions in Q1 2020 and 24 closed out, a net change of +1 holder.
  • The largest GenMark Diagnostics, Inc buyer in Q1 2020 was Portolan Capital Management, an estimated $4.19M added.
  • The largest GenMark Diagnostics, Inc seller in Q1 2020 was Cadian Capital Management, an estimated $9.51M sold.

Based on aggregated 13F filings for Q1 2020.